Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: StockMiser who wrote (926)	6/29/1999 11:44:00 AM
From: Garry K.	Read Replies (1) of 2344

StockMiser: My strategy with this company mimmicks yours...buying on the dips and holding on at least 18-24 months. We may see some small spikes if there are progress reports or additional milestones made on other products in the pipeline. However, I don't think we will see dramatic price appreciation until full enrollment has been made in Phase III. Institutional investors would likely wait and see until then as there is too much potential risk at the present time. I think there has been some disappointed investors who thought they may make a quick buck on this company -- it is still possible to see a good spike if there is some type of surprise. However, this is a quality hold for a patient investor. Given time, this gem will shine. Good luck! Garry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next